Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Plunkett

Showing results (191-200 of 244) with videos related to

Pageof 25
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1996
Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAXD J McConkey, J Chandra, S Wright, et al.
Leukemia & Lymphoma|April 11, 2003
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemiaM J Keating, S O'Brien, D Kontoyiannis, et al.
Blood|January 1, 1993
Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenineL E Robertson, S Chubb, R E Meyn, et al.
Dermatology (Basel, Switzerland)|April 9, 2002
Diagnostic features of pemphigus vulgaris in patients with bullous pemphigoid. Molecular analysis of autoantibody profileNaveed Sami, Kailash C Bhol, Ernst H Beutner, et al.
Cancer Research|January 19, 1999
Enhancement of tumor radioresponse in vivo by gemcitabineL Milas, T Fujii, N Hunter, et al.
Leukemia & Lymphoma|October 1, 1996
What does apoptosis mean in CLL?J L Binet, W Plunkett, B Robertson, et al.
Biochemical Pharmacology|October 15, 1982
Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartateE C Moore, J Friedman, M Valdivieso, et al.
Molecular Pharmacology|October 1, 1990
Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidineV Heinemann, Y Z Xu, S Chubb, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabineL E Robertson, A W Denny, Y O Huh, et al.
Leukemia|February 17, 2006
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-CH Pelicano, J S Carew, T J McQueen, et al.
Pageof 25

Showing results (191-200 of 244) with videos related to

Sort By:
Pageof 25
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1996
Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAXD J McConkey, J Chandra, S Wright, et al.
Leukemia & Lymphoma|April 11, 2003
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemiaM J Keating, S O'Brien, D Kontoyiannis, et al.
Blood|January 1, 1993
Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenineL E Robertson, S Chubb, R E Meyn, et al.
Dermatology (Basel, Switzerland)|April 9, 2002
Diagnostic features of pemphigus vulgaris in patients with bullous pemphigoid. Molecular analysis of autoantibody profileNaveed Sami, Kailash C Bhol, Ernst H Beutner, et al.
Cancer Research|January 19, 1999
Enhancement of tumor radioresponse in vivo by gemcitabineL Milas, T Fujii, N Hunter, et al.
Leukemia & Lymphoma|October 1, 1996
What does apoptosis mean in CLL?J L Binet, W Plunkett, B Robertson, et al.
Biochemical Pharmacology|October 15, 1982
Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartateE C Moore, J Friedman, M Valdivieso, et al.
Molecular Pharmacology|October 1, 1990
Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidineV Heinemann, Y Z Xu, S Chubb, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabineL E Robertson, A W Denny, Y O Huh, et al.
Leukemia|February 17, 2006
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-CH Pelicano, J S Carew, T J McQueen, et al.
Pageof 25